Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
Viral infections cause many severe human diseases, being responsible for remarkably high mortality rates. In this sense, both the academy and the pharmaceutical industry are continuously searching for new compounds with antiviral activity, and in addition, face the challenge of developing greener an...
Main Authors: | Everton M. da Silva, Hérika D. A. Vidal, Arlene G. Corrêa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/11/1125 |
Similar Items
-
New advances in asymmetric organocatalysis
by: Radovan Šebesta
Published: (2022-02-01) -
Evolution of design approaches in asymmetric organocatalysis over the last decade
by: Nika Melnyk, et al.
Published: (2023-03-01) -
Asymmetric Organocatalysis: A Survival Guide to Medicinal Chemists
by: Efraim Reyes, et al.
Published: (2022-12-01) -
Asymmetric Organocatalysis with Chiral Covalent Organic Frameworks
by: Song-Chen Yu, et al.
Published: (2021-04-01) -
Asymmetric organocatalyzed synthesis of coumarin derivatives
by: Natália M. Moreira, et al.
Published: (2021-08-01)